Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Amgen

Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test

Ionis stock tumbled Friday after partner AstraZeneca decided against sending their high cholesterol treatment into Phase 3 testing.

Investors Business Daily

Amgen Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Amgen. Looking at options history for Amgen (NASDAQ:AMGN) we detected 22 strange trades.

Benzinga

Bristol Myers Stock Surges After FDA Approves New Plaque Psoriasis Treatment; Amgen Slides

“We believe Sotyktu is a breakthrough in the treatment of patients suffering from moderate-to-severe plaque psoriasis," said Bristol Myers' chief medical officer Samit Hirawat.

The Street

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Amgen's Cancer Drug Results Gave This Small Cap A Big Boost

Amgen stock jumped Wednesday after outperforming expectations in a lung-cancer study. It brought rival Mirati along for the ride.

Investors Business Daily

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

Amgen (NASDAQ:AMGN) announced top-line results from the global Phase 3 CodeBreaK 200 trial evaluating once daily oral LUMAKRAS (sotorasib) in patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC), the study met primary endpoint. Amgen shares traded in a range of $238.29 to $240.31 on day volume of 2.43 million shares, closed regular…

Benzinga

2 Biotech Stocks to Buy and Hold for the Long Term

Intensive innovation, breakthrough developments, and growing investments should help the biotech industry witness solid growth over the next decade. And given the sector’s reputation as a safe haven amid economic turmoil, it could be wise for investors to buy and hold fundamentally solid biotech stocks Amgen (AMGN) and AstraZeneca (AZN)…

StockNews.com

Competitive drug prices are great for consumers. Turns out, they're good for industry, too.

The Street

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Falls As Powell Warns Of 'Some Pain' To Fight Inflation

The Dow Jones Industrial Average reversed lower Friday, as Federal Reserve Chairman Jerome Powell warned of "some pain" to fight inflation.

Investors Business Daily

Take Advantage Of Low Volatility In Amgen Stock With Options

Amgen is showing very low implied volatility compared to recent history. That could mean it’s a good time to buy an option strangle.

Investors Business Daily

Dow Jones Falls After Key Economic Data; Peloton Dives 18% On Earnings

The Dow Jones Industrial Average fell Thursday after key economic data. Peloton dived 18% on earnings, while Tesla stock rallied post-split.

Investors Business Daily

Dow Jones Falls As Tesla Climbs Ahead Of 3:1 Stock Split

The Dow Jones Industrial Average fell Wednesday, extending a losing streak. Tesla stock climbed ahead of Thursday's 3:1 stock split.

Investors Business Daily

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Merck's (NYSE:MRK) lead asset MK-2060 for the reduction in risk of major thrombotic cardiovascular events in patients with end-stage renal disease (ESRD). Merck shares traded in a range of $89.72 to $90.97 on day volume of 5.2…

Benzinga

Dow Jones Falls After Stock Market Plunge; Zoom Video Dives On Earnings

The Dow Jones Industrial Average fell Tuesday, adding to Monday's stock market plunge. Zoom Video stock dived on earnings.

Investors Business Daily

5 Biotech Stocks in the Buy Zone This Week

The biotech industry is expected to see solid growth in the long term due to rising healthcare spending, breakthrough developments, and an aging population. Given the industry’s solid growth prospects and non-cyclical nature, it could be wise to invest in fundamentally strong biotech stocks Gilead Sciences (GILD), Biogen (BIIB), Jazz…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

This Is What Whales Are Betting On Amgen

A whale with a lot of money to spend has taken a noticeably bullish stance on Amgen. Looking at options history for Amgen (NASDAQ:AMGN) we detected 10 strange trades.

Investors Business Daily

Stock Market Ends Upbeat Week With Mixed Results On Hot Job Numbers

The stock market traded mixed on Friday on hot job numbers, closing out the week with gains. AMC popped on earnings beat.

Investors Business Daily

Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review

The stock market rally had mixed action, with the Nasdaq and small caps rising while the S&P 500 and oil prices fell.

Investors Business Daily

Dow Jones Slides On Strong Jobs Report; Square Stock Dives On Earnings; Tesla Stock Split Approved

The Dow Jones Industrial Average dropped Friday on a strong jobs report. And shareholders approved plans for a 3-for-1 Tesla stock split.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.

Benzinga

Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday

U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.

Investors Business Daily

Dow Jones Futures: Jobs Report Tests 'Soft Landing' Market Rally; Tesla Stock Split Approved

The indexes were quiet before the July jobs report tests the Fed's soft landing. Tesla shareholders OK'd a 3-for-1 stock split.

Benzinga

What Are Whales Doing With Amgen

Someone with a lot of money to spend has taken a bearish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Investors Business Daily

Amgen Narrows Sales Outlook Following Plans To Acquire ChemoCentryx

Amgen narrowed its outlook for 2022 sales after its second-quarter beat. But Amgen stock fell just a fraction on Friday.

Benzinga

Gold Tops 1,800; Alibaba Reports Upbeat Results

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 75 points on Thursday

Investors Business Daily

Stock Market In Consolidation; Energy Sells Off For Second Day

The Nasdaq composite is showing minor strength, higher by less than 0.1%.

1 … 9 10 11 12

People

Jerome Powell

2,728 stories

Dipanjan BanchurSince

722 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.